Clinical Trial

The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 11, 2025 (before its estimated December 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
An inadequate amount of peri-implant soft tissue results in more plaque accumulation around the implants, peri-implant mucositis, marginal bone loss, mucosal recession, and/or attachment loss. In the literature, there are studies evaluating the application of injectable platelet-rich fibrin to the gingiva and oral mucosa around teeth, but injectable platelet-rich fibrin application around implants has not been encountered. This study aimed to evaluate the effect of subgingival and submucosal application of injectable platelet-rich fibrin on peri-implant soft tissue phenotype in patients with inadequate peri-implant soft tissue phenotype.The study will include 80 systemically healthy and non-smoking patients/implants older than 18 years of age with insufficient peri-implant keratinized mucosa width and mucosal thickness who applied to Kütahya University of Health Sciences, Faculty of Dentistry, Department of Periodontology. There are two study groups according to peri-implant mucosa phenotype: Thin phenotype and thick phenotype. All patients will undergo the same procedure of injectable platelet-rich fibrin application
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-20.
Trial Details
NCT Number NCT06753396
Lead Sponsor Kutahya Health Sciences University
Conditions Peri-Implant Tissues
Enrollment 80 participants
Start Date 2022-12-15
Primary Completion 2025-12-15 (estimated)
Study Completion 2026-04-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-11